HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

M Caproni Selected Research

Stevens-Johnson Syndrome (Lyell's Syndrome)

1/2022Stevens-Johnson syndrome induced by Vaxvetria (AZD1222) COVID-19 vaccine.
4/2009Interleukin 8 as a chemoattractant for neutrophil granulocytes in toxic epidermal necrolysis lesions.
5/2008Expression of matrix metalloproteinases 2, 9 and 11 in erythema multiforme: immunohistochemical comparison with Stevens-Johnson syndrome/toxic epidermal necrolysis.
1/2008Serum interleukin-13 levels are increased in patients with Stevens-Johnson syndrome/ toxic epidermal necrolysis but not in those with erythema multiforme.
10/2006Expression of cytokines and chemokine receptors in the cutaneous lesions of erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis.
5/2006Elevated circulating CD40 ligand in patients with erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis spectrum.
2/2006The CD40/CD40 ligand system is expressed in the cutaneous lesions of erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis spectrum.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


M Caproni Research Topics

Disease

7Stevens-Johnson Syndrome (Lyell's Syndrome)
01/2022 - 02/2006
7Psoriasis (Pustulosis Palmaris et Plantaris)
05/2011 - 01/2001
5Dermatitis Herpetiformis (Disease, Duhring's)
06/2021 - 01/2001
5Inflammation (Inflammations)
04/2015 - 10/2004
5Dermatomyositis (Dermatopolymyositis)
10/2014 - 01/2002
5Atopic Dermatitis (Atopic Eczema)
05/2011 - 04/2000
5Chronic Urticaria
05/2010 - 10/2003
5Erythema Multiforme
05/2008 - 02/2006
4Bullous Pemphigoid (Pemphigoid)
10/2021 - 11/2008
4Cutaneous Lupus Erythematosus
04/2019 - 08/2009
2Systemic Lupus Erythematosus (Libman-Sacks Disease)
12/2023 - 05/2011
2Pemphigus (Pemphigus Vulgaris)
09/2020 - 02/2001
2Cicatrix (Scar)
03/2017 - 04/2005
2Pyoderma Gangrenosum
01/2017 - 10/2014
2Sweet Syndrome (Acute Febrile Neutrophilic Dermatosis)
01/2017 - 10/2014
2Skin Diseases (Skin Disease)
10/2014 - 01/2003
2Prurigo
06/2013 - 08/2006
2Necrosis
10/2006 - 10/2004
1COVID-19
12/2023
1Neoplasms (Cancer)
10/2021
1Livedo Reticularis
04/2019
1Purpura
04/2019
1Telangiectasis (Telangiectasia)
04/2019
1Acne Vulgaris
04/2015
1Vasculitis (Vasculitides)
04/2015
1Systemic Scleroderma (Systemic Sclerosis)
10/2014
1Connective Tissue Diseases (Connective Tissue Disease)
10/2014
1Localized Scleroderma (Morphea)
10/2014
1Annular Erythema
03/2013
1Vesiculobullous Skin Diseases (Subcorneal Pustular Dermatosis)
10/2012
1Discoid Lupus Erythematosus
05/2011
1Gingivitis
11/2008

Drug/Important Bio-Agent (IBA)

10CytokinesIBA
10/2014 - 02/2001
7AntibodiesIBA
01/2021 - 01/2002
6AutoantibodiesIBA
04/2019 - 06/2003
6InterleukinsIBA
01/2017 - 02/2001
5CD40 Ligand (CD40L)IBA
01/2017 - 10/2004
4Immunoglobulin A (IgA)IBA
06/2021 - 08/2006
4Chemokine ReceptorsIBA
01/2017 - 10/2004
3Matrix Metalloproteinases (MMPs)IBA
10/2021 - 05/2008
3Interleukin-13IBA
01/2017 - 10/2004
3InterferonsIBA
01/2017 - 02/2001
3Interleukin-5 (Interleukin 5)IBA
01/2017 - 10/2004
3Interleukin-4 (Interleukin 4)IBA
01/2017 - 10/2004
3ChemokinesIBA
10/2014 - 10/2004
3Fas Ligand Protein (Fas Ligand)IBA
10/2014 - 10/2005
3Tacrolimus (Prograf)FDA LinkGeneric
04/2011 - 11/2006
3Ointments (Pastes)IBA
04/2011 - 01/2005
3Monoclonal AntibodiesIBA
10/2006 - 02/2001
3Phosphoric Monoester Hydrolases (Phosphatases)IBA
10/2004 - 01/2001
3Tryptases (Tryptase)IBA
10/2004 - 01/2001
3Alkaline PhosphataseIBA
10/2004 - 01/2001
2Etanercept (Enbrel)FDA Link
07/2010 - 03/2009
2AcitretinFDA Link
07/2010 - 03/2009
2Interleukin-8 (Interleukin 8)IBA
04/2009 - 07/2006
2Histamine Antagonists (Antihistamines)IBA
12/2006 - 01/2001
2Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA
12/2006 - 01/2003
2CC ChemokinesIBA
10/2006 - 10/2004
2CXC ChemokinesIBA
10/2006 - 10/2004
2Immunoglobulin E (IgE)IBA
07/2006 - 10/2003
2IgE Receptors (Fc epsilon RI)IBA
07/2006 - 10/2003
2Peroxidase (Myeloperoxidase)IBA
10/2004 - 02/2001
2Eosinophil Cationic ProteinIBA
10/2004 - 02/2001
2Cetirizine (Zyrtec)FDA LinkGeneric
01/2003 - 01/2001
2Cyclosporine (Ciclosporin)FDA LinkGeneric
11/2001 - 04/2000
1Messenger RNA (mRNA)IBA
12/2023
1ChAdOx1 nCoV-19IBA
01/2022
1COVID-19 VaccinesIBA
01/2022
1KalininIBA
10/2021
1Glutens (Glutelin)IBA
06/2021
1TransglutaminasesIBA
01/2021
1Rituximab (Mabthera)FDA Link
09/2020
1anti-dsDNA autoantibodyIBA
04/2019
1Nuclear Antigens (Extractable Nuclear Antigens)IBA
04/2019
1Antimalarials (Antimalarial Agents)IBA
03/2017
1Interleukin-15 (Interleukin 15)IBA
01/2017
1Docetaxel (Taxotere)FDA Link
04/2016
1AndrogensIBA
04/2015
1NeuropeptidesIBA
04/2015
1beta-cyclodextrin tetradecasulfate (CTDS)IBA
10/2014
1Transforming Growth Factors (Transforming Growth Factor)IBA
05/2011
1Interleukin-10 (Interleukin 10)IBA
05/2011
1Toll-Like Receptors (Toll-Like Receptor)IBA
04/2011
1Granzymes (Granzyme)IBA
08/2010
1Tretinoin (Retinoic Acid)FDA LinkGeneric
07/2010
1efalizumab (Raptiva)FDA Link
04/2009
1Chemotactic FactorsIBA
04/2009
1Interleukin-22 (IL-22)IBA
03/2009
1Interleukin-17 (Interleukin 17)IBA
03/2009
1Interleukin-23 (Interleukin 23)IBA
03/2009
1Hydrocortisone (Cortisol)FDA LinkGeneric
02/2007
1Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA
12/2006
1P-SelectinIBA
12/2006
1levocetirizineFDA LinkGeneric
12/2006
1hydrocortisone-17-butyrate (Locoid)FDA LinkGeneric
11/2006
1CCR3 ReceptorsIBA
10/2006
1Interleukin-13 Receptors (Interleukin 13 Receptor)IBA
10/2006

Therapy/Procedure

3Therapeutics
06/2021 - 12/2006
2Aftercare (After-Treatment)
03/2009 - 01/2001
1Gluten-Free Diet
06/2009